Redox status of plasma coenzyme Q10 indicates elevated systemic oxidative stress in Parkinson's disease. - Wikidata - wikimedia - TriplyDB

Redox status of plasma coenzyme Q10 indicates elevated systemic oxidative stress in Parkinson's disease.

Redox status of plasma coenzyme Q10 indicates elevated systemic oxidative stress in Parkinson's disease.

http://www.wikidata.org/entity/Q53263850

about

The promise of neuroprotective agents in Parkinson's disease Mitochondrial modulators for bipolar disorder: A pathophysiologically informed paradigm for new drug development Statin adverse effects : a review of the literature and evidence for a mitochondrial mechanism Old Things New View: Ascorbic Acid Protects the Brain in Neurodegenerative Disorders The role of biomarkers and imaging in Parkinson's disease.Neuroprotective effects of compounds with antioxidant and anti-inflammatory properties in a Drosophila model of Parkinson's disease Coenzyme q10 therapy Protective efficacy of coenzyme Q10 against DDVP-induced cognitive impairments and neurodegeneration in rats.Total cholesterol and the risk of Parkinson's disease: a review for some new findings.Therapeutic effects of coenzyme Q10 (CoQ10) and reduced CoQ10 in the MPTP model of Parkinsonism.The many roads to mitochondrial dysfunction in neuroimmune and neuropsychiatric disorders LK6/Mnk2a is a new kinase of alpha synuclein phosphorylation mediating neurodegeneration Coenzyme Q10 deficiency in patients with Parkinson's disease.Antioxidants, supplements, and Parkinson's disease.Genetic findings in Parkinson's disease and translation into treatment: a leading role for mitochondria?Quantitative proteomics of a presymptomatic A53T alpha-synuclein Drosophila model of Parkinson disease.Coenzyme Q10: is there a clinical role and a case for measurement?Coenzyme Q10 serum concentration and redox status in European adults: influence of age, sex, and lipoprotein concentration Smoking habits and coenzyme Q10 status in healthy European adults.Oxidative stress in Parkinson's disease: a mechanism of pathogenic and therapeutic significance.Stable isotope labeling and label-free proteomics of Drosophila parkin null mutants.Coenzyme Q10 effects in neurodegenerative disease.Therapeutic use of coenzyme Q10 and coenzyme Q10-related compounds and formulations.Association of serum carotenoid, retinol, and tocopherol concentrations with the progression of Parkinson's Disease.Blood-based protein biomarkers for diagnosis and classification of neurodegenerative diseases: current progress and clinical potential.Biomarkers for trials of neuroprotection in Parkinson's disease.LXR agonists: new potential therapeutic drug for neurodegenerative diseases.Association Between Serum Zinc Levels and the Risk of Parkinson's Disease: a Meta-Analysis.Impact of genetic variants of apolipoprotein E on lipid profile in patients with Parkinson's disease Do mtDNA Mutations Participate in the Pathogenesis of Sporadic Parkinson's Disease?Physical activity affects plasma coenzyme Q10 levels differently in young and old humans.Oxidative Stress: Mechanistic Insights into Inherited Mitochondrial Disorders and Parkinson's Disease.Coenzyme Q10, hyperhomocysteinemia and MTHFR C677T polymorphism in levodopa-treated Parkinson's disease patients.Oxidized proportion of muscle coenzyme Q10 increases with age in healthy children.A pilot clinical trial of the effects of coenzyme Q10 on chronic tinnitus aurium.Increased oxidative stress and renal injury in patients with sepsis Effect of a single intrastriatal rotenone injection on oxidative stress and neurodegeneration in the rat brain Antioxidant and Oxidative Stress: A Mutual Interplay in Age-Related Diseases Recent Advances in Biomarkers for Parkinson's Disease

P2860

Q21129436-91996809-032A-4CB4-B1D1-1B04052B43CB Q22241837-A3CD5F59-BDC0-453F-AFE6-BF9DB68CDDC9 Q24603957-DF0BF498-7903-4088-84D9-FCFCA7E2D4BA Q26775096-F0CAC23B-27C8-4CD8-ADC0-95CF050A1E67 Q31041660-421E01F2-A173-4C10-AEAC-D7B7B5B2E8BB Q33499111-0E1B7C19-95C2-40A1-80EF-CFDCB01112DB Q33956936-F819FC00-8F38-4E43-B1C9-7B735939C17F Q34074327-3ECEF3FC-8B56-438E-A4C1-01A2B1C4F3FB Q34212035-D2A24AFE-788E-4E3F-AE9B-D2BF2156BF38 Q34584417-4BB29C1F-197B-406B-886C-53CE8C9BF29D Q35246024-9614EAFA-37A2-48A5-A26A-A91F3433BF18 Q35898177-AC3511EC-1192-4228-9C90-F92A5196B882 Q36003957-0F45C2DF-47E4-4175-B0E2-9ADFE33905B3 Q36452468-91C9E0F4-A829-4041-9542-890790F49AB6 Q36499640-CDBC5FEA-94B0-4D35-AE99-AF49B5DBD671 Q36804685-F7CAB9B6-AEDB-4232-9499-4D4CE99F0B16 Q36869671-3B81A061-BDE6-4C4C-A769-F126FB1EF0F2 Q36897158-A3FCA5AB-F893-4115-AD0C-31360104CDE0 Q37100514-F4D42F83-47B6-4F68-B6E4-8059E89D5756 Q37348548-BE4D8B6A-BD19-4C9C-93AA-FC4E40D6C236 Q37398849-D6006FB3-0645-40D0-9091-CA17B16F1163 Q37448888-65E437E6-2350-434A-AA7F-10927A6E6623 Q37724200-124A3CF4-B312-473E-BEA1-B440C8B554A8 Q37733665-99A72EBB-52C2-4610-8C69-F51C0700CE65 Q37881948-AF8E3400-58D5-4EA1-BB5A-89A2ED0CE42A Q38038544-1654839E-B3B7-4F44-BDD1-492D9198F4AB Q38102608-A183877C-C58F-4238-A07A-5C715673A79F Q39119173-A8C94951-2EC3-410C-8DAF-C3ACE9899DD3 Q42181761-661B8570-2273-4DD1-ACCE-52A8F189B157 Q42921452-54880D84-FDCB-43F4-971B-CD5E20028968 Q45841858-DBF63542-90DA-4F11-88A2-A44AB94CA02D Q46273409-733EEDC4-AD79-4246-A8A5-0E0BCCB41F8D Q51418735-6401274D-AE74-46CD-91B0-0E8FE8C3EE42 Q51618527-46F5EF0F-C35E-41A8-BFCD-667F39DA619B Q52928102-A8246A8E-3609-4E57-ABE9-BAC8BB4F51F6 Q57125073-F980D5C4-578E-44B8-B7E5-04EC6B14ADA1 Q57729898-96C7646B-BF7D-4ED7-86A8-AFF8C78E8EBE Q58554131-82265A65-D506-48C0-95FD-71588625941B Q58572579-E5E3986C-8A0C-4A25-904B-C30CE43ACBF4

P2860

Redox status of plasma coenzyme Q10 indicates elevated systemic oxidative stress in Parkinson's disease.

http://www.wikidata.org/entity/Q53263850

description

2004 nî lūn-bûn

@nan

2004年の論文

@ja

2004年学术文章

@wuu

2004年学术文章

@zh

2004年学术文章

@zh-cn

2004年学术文章

@zh-hans

2004年学术文章

@zh-my

2004年学术文章

@zh-sg

2004年學術文章

@yue

2004年學術文章

@zh-hant

name

Redox status of plasma coenzym ...... stress in Parkinson's disease.

@en

Redox status of plasma coenzym ...... stress in Parkinson's disease.

@nl

type

label

Redox status of plasma coenzym ...... stress in Parkinson's disease.

@en

Redox status of plasma coenzym ...... stress in Parkinson's disease.

@nl

prefLabel

Redox status of plasma coenzym ...... stress in Parkinson's disease.

@en

Redox status of plasma coenzym ...... stress in Parkinson's disease.

@nl

P1433

Q53263850-A726DA08-2771-4A33-AD65-9DAC110B71AF

P1476

Q53263850-EB18FB02-BD69-4075-A2C1-A98F474CE506

P2093

Q53263850-3F8CA5FB-0678-4497-8CFE-38E6D27335C7

Q53263850-675A321D-8C4F-46DF-8695-9652D7D2C8F9

Q53263850-6BE56F78-8861-4875-8A1A-47B5314257A0

Q53263850-80228F66-DE67-41CA-9F9A-85255AA92A9C

Q53263850-9405C2B0-CCE0-4BD2-A67A-D4DBBC7FF482

Q53263850-BF4F8F6A-5EB4-4C43-A5C0-DA32A0CF4666

Q53263850-CD31F32F-CE4E-4FEB-8DC8-2F40E2A662A8

Q53263850-F8E0D906-D247-467C-BD4B-513F141980C0

P304

Q53263850-EFDCA6AF-3ABC-40FC-A6D5-BF6F90305532

P31

Q53263850-5F45F3E8-EEFC-420E-90AC-5B4EC959D769

P356

Q53263850-FED2B0AC-BBE8-46D3-93B9-C4A1EA256AB6

P433

Q53263850-87E47A47-F928-4291-A93F-8B7BD9104840

P478

Q53263850-1EF00062-A764-4FBB-8F89-C7754144F5D2

P577

Q53263850-EE315521-1822-4254-8C14-C468436ED445

P698

Q53263850-5317A6B9-BBFE-491B-B02D-02F430FD286C

P921

Q53263850-CD0DC6E9-29E6-4B2F-A00F-2B33E525FBFB

Q53263850-DEE41C66-F339-43CC-9649-BD1B9A1BD2CA

P356

J.JNS.2004.05.007

P1433

Journal of the Neurological Sciences

P1476

Redox status of plasma coenzym ...... stress in Parkinson's disease.

@en

P2093

Koichi Okamoto

http://www.w3.org/2001/XMLSchema#string

Makoto Sohmiya

http://www.w3.org/2001/XMLSchema#string

Makoto Tanaka

http://www.w3.org/2001/XMLSchema#string

Makoto Yanagisawa

http://www.w3.org/2001/XMLSchema#string

Nyou Wei Tak

http://www.w3.org/2001/XMLSchema#string

Yoko Suzuki

http://www.w3.org/2001/XMLSchema#string

Yorihiro Yamamoto

http://www.w3.org/2001/XMLSchema#string

Yutaka Tanino

http://www.w3.org/2001/XMLSchema#string

P304

161-166

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.JNS.2004.05.007

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

223

http://www.w3.org/2001/XMLSchema#string

P577

2004-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15337618

http://www.w3.org/2001/XMLSchema#string

P921

Parkinson's disease